Identification of a Five-Gene Signature Derived From MYCN Amplification and Establishment of a Nomogram for Predicting the Prognosis of Neuroblastoma.
Identification of a Five-Gene Signature Derived From MYCN Amplification and Establishment of a Nomogram for Predicting the Prognosis of Neuroblastoma.
复制标题
MYCN 扩增衍生的五基因特征的鉴定以及用于预测神经母细胞瘤预后的诺模图的建立
DOI:
10.3389/fmolb.2021.769661
复制
发表时间:
2021
影响因子:
5
通讯作者:
Zhao Q
中科院分区:
文献类型:
--
作者:
Xia Y;Li X;Tian X;Zhao Q
Background: Neuroblastoma (NB), the most common solid tumor in children, exhibits vastly different genomic abnormalities and clinical behaviors. While significant progress has been made on the research of relations between clinical manifestations and genetic abnormalities, it remains a major challenge to predict the prognosis of patients to facilitate personalized treatments. Materials and Methods: Six data sets of gene expression and related clinical data were downloaded from the Gene Expression Omnibus (GEO) database, ArrayExpress database, and Therapeutically Applicable Research to Generate Effective Treatments (TARGET) database. According to the presence or absence of MYCN amplification, patients were divided into two groups. Differentially expressed genes (DEGs) were identified between the two groups. Enrichment analyses of these DEGs were performed to dig further into the molecular mechanism of NB. Stepwise Cox regression analyses were used to establish a five-gene prognostic signature whose predictive performance was further evaluated by external validation. Multivariate Cox regression analyses were used to explore independent prognostic factors for NB. The relevance of immunity was evaluated by using algorithms, and a nomogram was constructed. Results: A five-gene signature comprising CPLX3, GDPD5, SPAG6, NXPH1, and AHI1 was established. The five-gene signature had good performance in predicting survival and was demonstrated to be superior to International Neuroblastoma Staging System (INSS) staging and the MYCN amplification status. Finally, a nomogram based on the five-gene signature was established, and its clinical efficacy was demonstrated. Conclusion: Collectively, our study developed a novel five-gene signature and successfully built a prognostic nomogram that accurately predicted survival in NB. The findings presented here could help to stratify patients into subgroups and determine the optimal individualized therapy.
登录
查看更多内容
DOI:
10.1093/jnci/djt006
发表时间:
2013-03-20
期刊:
Journal of the National Cancer Institute
影响因子:
--
作者:
Chen M;Gallipoli P;DeGeer D;Sloma I;Forrest DL;Chan M;Lai D;Jorgensen H;Ringrose A;Wang HM;Lambie K;Nakamoto H;Saw KM;Turhan A;Arlinghaus R;Paul J;Stobo J;Barnett MJ;Eaves A;Eaves CJ;Holyoake TL;Jiang X
通讯作者:
Jiang X
DOI:
10.1097/pas.0000000000001647
发表时间:
2021-08-01
期刊:
The American journal of surgical pathology
影响因子:
--
作者:
Kawano A;Hazard FK;Chiu B;Naranjo A;LaBarre B;London WB;Hogarty MD;Cohn SL;Maris JM;Park JR;Gastier-Foster JM;Ikegaki N;Shimada H
通讯作者:
Shimada H
影响因子:
5.4
作者:
Huang M;Weiss WA
通讯作者:
Weiss WA
影响因子:
15.9
作者:
Gu-Trantien, Chunyan;Loi, Sherene;Willard-Gallo, Karen
通讯作者:
Willard-Gallo, Karen
影响因子:
4.8
作者:
Faryna, Marta;Konermann, Carolin;Gerhauser, Clarissa
通讯作者:
Gerhauser, Clarissa